Profile

Corporate Name
Alfresa Pharma Corporation
Address
Headquarters:
2-2-9 Kokumachi, Chuo-ku, Osaka 540-8575, Japan
TEL. +81-6-6941-0300 FAX. +81-6-6947-1548
Incorporation
December 24, 1939
Capital
3 billion yen
President&CEO
Koichi Shimada
Number of Employees
1,074 employees (as of April 1, 2022)
Description of Business
Manufacture, import, export and marketing of pharmaceuticals, diagnostic products, medical devices, pharmaceutical raw materials, etc.
Banks
MUFG Bank, Ltd.

History

Alfresa Pharma Corporation

1920:
Nakashima Shigeru Shoten is founded as an importer and distributor of pharmaceuticals and medical devices in Manila, the Republic of Philippines.
1939:
Incorporated Nakajima Shigeru Shoten in Osaka, Japan.
1952:
Corporate name changes to Nippon Shoji Kaisha, Ltd.
1998:
Nippon Shoji and Showa Pharmaceuticals merge to form AZWELL Inc.
2003:
AZWELL Inc. and Fukujin Co., Ltd. merged to found Alfresa Holdings Corporation.
2004:
Alfresa Pharma Corporation was created.
2006:
Ibaraki Research Center, Okayama Plant, and Chiba Plant obtained the ISO13485:2003 certification.
2015:
Took over the Akita Plant of Daiichi Sankyo Propharma Co., Ltd., and established Alfresa Fine Chemical Corporation.

Sannova Co., Ltd.

1923:
Started business as a pharmaceuticals developer and manufacturer under the name of Sansho Co., Ltd.
1933:
The business expanded due to the success of the liver oil tablet, "Haliva."
1965:
started full-scale production of pharmaceuticals for Eisai Co., Ltd.
1968:
Became a subsidiary of Eisai Co., Ltd.
1986:
Eisai Co., Ltd. released the medicine for iron-deficiency, anemia, developed by ourself.
1989:
Acquired an authorization of contract manufacturing from Eisai Co., Ltd.
1996:
Transitioned into a large company under commercial law based on increased capital.
1997:
Started production of barrier-free medicines, marketed by Elmed Eisai Co., Ltd.
Acquired a manufacturing authorization of liquid-, ointment-, and cream-form medicines from Eisai Co., Ltd.
1998:
Relocated the headquarters to Serada-Cho, Ota City, Gunma (previously known as Ojima-machi, Nitta-gun).
1999:
Completed relocation of whole company to Serada-Cho, Ota City, Gunma.
Changed the corporate name to Sannova Co., Ltd.
2001:
Obtained the ISO 14001 certification.
2004:
Established new drainage treatment facilities.
2016:
Sannova Co., Ltd. became a wholly owned subsidiary of Alfresa Holdings Corporation.
2023:
Alfresa Pharma Corporation and Sannova Co., Ltd. merged together.

Group Companies

Alfresa Pharma is a member of the Alfresa family of companies. For more on our group philosophy, mission and vision, please visit the website of Alfresa Holdings at http://www.alfresa.com/eng/index.html